June 11, 1960


Author Affiliations

University of Minnesota Hospitals Minneapolis 14.

JAMA. 1960;173(6):710. doi:10.1001/jama.1960.03020240097024

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  In reviewing the current status of the therapy of human brucellosis at the request of the A. M. A. Council on Drugs, I used not only the results of our own experience but also the reports of the committee on brucellosis of the National Research Council and of the expert committee on brucellosis of the World Health Organization. Since many investigators of human brucellosis do not agree with the opinions of Dr. Harris on the diagnosis and treatment of chronic brucellosis, a brief note of explanation is in order concerning the basis for this disagreement.Most authorities agree that acute brucellosis occurs much more commonly than chronic brucellosis if one adheres to dependable diagnostic criteria, including serologic and bacteriological data. Dr. Harris also agrees that these rigid criteria should be used in the diagnosis of acute and subacute brucellosis. Furthermore, he states that brucella vaccine should not

First Page Preview View Large
First page PDF preview
First page PDF preview